E.V.N. Pharma SRL
2.3 FTEThe score of E.V.N. Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +71 % Total assets +59 % Headcount (avg FTE) +10 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
E.V.N. Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jul 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 02 Aug 2024
- Year ended 31 Dec 2022filed on 18 Jul 2023
- Year ended 31 Dec 2021filed on 01 Aug 2022
E.V.N. Pharma's financial analysis
- Solvency33.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of E.V.N. Pharma
E.V.N. Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0871.125.128
- VAT number
- BE0871125128
- Peppol
- Registered · 0208:0871125128 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Jan 2005
- Registered office
- 1850 Grimbergen
- Size
- Micro · 2.3 FTE
- Latest accounts
- 2025 · filed on 22 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
E.V.N. Pharma (SRL) has been based in Grimbergen since 2005, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 238,519 € and equity of €1.09m; its revenue is not published. With 2.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 33.3%, below the median of its sector (44.2%).
Companies similar to E.V.N. Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- GDK Farma Retail sale of pharmaceutical products Grimbergen · balance sheet €3.07m
- Xpharma Retail sale of pharmaceutical products Puurs-Sint-Amands · balance sheet €3.07m
- Extra-Pharma Retail sale of pharmaceutical products Kapellen · balance sheet €3.06m
- Unifarma Retail sale of pharmaceutical products Kortrijk · balance sheet €3.56m
- VAN Nuffel - DE Vriendt Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet €2.84m
- Crossver Retail sale of pharmaceutical products Wielsbeke · balance sheet €3.78m
- Apotheek Devriese Retail sale of pharmaceutical products Torhout · balance sheet €3.84m
Frequently asked questions about E.V.N. Pharma
What is the revenue of E.V.N. Pharma?
E.V.N. Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of E.V.N. Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0871125128 for E.V.N. Pharma, if the company is VAT-registered. Its company number (CBE) is 0871.125.128.
Where is the registered office of E.V.N. Pharma?
According to the CBE register, the registered office of E.V.N. Pharma is in 1850 Grimbergen.
What is the equity of E.V.N. Pharma?
At the close of the 2025 financial year, the equity of E.V.N. Pharma amounts to 1,091,395 €, a solvency of 33.3% of total assets.
How many people work at E.V.N. Pharma?
2.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages E.V.N. Pharma?
The register lists 2 active mandates at E.V.N. Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of E.V.N. Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →